Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1705 to 1708 of 1708 entries
Sorted by: Best Match Show Resources per page
A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis.

Annals of hematology

Ichikawa S, Fujiwara T, Saito K, Fukuhara N, Yokoyama H, Hatta S, Onodera K, Onishi Y, Fujishima F, Ichinohasama R, Harigae H.
PMID: 32865606
Ann Hematol. 2021 Oct;100(10):2665-2668. doi: 10.1007/s00277-020-04241-w. Epub 2020 Aug 31.

No abstract available.

Cite
Ichikawa S, Fujiwara T, Saito K, et al. A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis. Ann Hematol. 2020;100(10):2665-2668doi: 10.1007/s00277-020-04241-w.
Ichikawa, S., Fujiwara, T., Saito, K., Fukuhara, N., Yokoyama, H., Hatta, S., Onodera, K., Onishi, Y., Fujishima, F., Ichinohasama, R., & Harigae, H. (2021). A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis. Annals of hematology, 100(10), 2665-2668. https://doi.org/10.1007/s00277-020-04241-w
Ichikawa, Satoshi, et al. "A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis." Annals of hematology vol. 100,10 (2021): 2665-2668. doi: https://doi.org/10.1007/s00277-020-04241-w
Ichikawa S, Fujiwara T, Saito K, Fukuhara N, Yokoyama H, Hatta S, Onodera K, Onishi Y, Fujishima F, Ichinohasama R, Harigae H. A novel case of γδ T cell leukemia with recurrent genetic abnormalities accompanied by agranulocytosis. Ann Hematol. 2021 Oct;100(10):2665-2668. doi: 10.1007/s00277-020-04241-w. Epub 2020 Aug 31. PMID: 32865606.
Copy Download .nbib Format: NLM
Lethal prognosis of an infant with intraperitoneal large venous malformation.

Journal of vascular surgery cases and innovative techniques

Ouchi K, Tsuchiya K, Iehara T, Nishimura A, Konishi E, Hosoi H.
PMID: 34401614
J Vasc Surg Cases Innov Tech. 2021 May 05;7(3):512-515. doi: 10.1016/j.jvscit.2021.04.006. eCollection 2021 Sep.

Intraperitoneal venous malformations are uncommon. Therefore, the prognosis of patients has not been determined, and appropriate treatments have not been established. We have reported the case of a neonate with an extensive intraperitoneal venous malformation. She did not have...

Cite
Ouchi K, Tsuchiya K, Iehara T, et al. Lethal prognosis of an infant with intraperitoneal large venous malformation. J Vasc Surg Cases Innov Tech. 2021;7(3):512-515doi: 10.1016/j.jvscit.2021.04.006.
Ouchi, K., Tsuchiya, K., Iehara, T., Nishimura, A., Konishi, E., & Hosoi, H. (2021). Lethal prognosis of an infant with intraperitoneal large venous malformation. Journal of vascular surgery cases and innovative techniques, 7(3), 512-515. https://doi.org/10.1016/j.jvscit.2021.04.006
Ouchi, Kazutaka, et al. "Lethal prognosis of an infant with intraperitoneal large venous malformation." Journal of vascular surgery cases and innovative techniques vol. 7,3 (2021): 512-515. doi: https://doi.org/10.1016/j.jvscit.2021.04.006
Ouchi K, Tsuchiya K, Iehara T, Nishimura A, Konishi E, Hosoi H. Lethal prognosis of an infant with intraperitoneal large venous malformation. J Vasc Surg Cases Innov Tech. 2021 May 05;7(3):512-515. doi: 10.1016/j.jvscit.2021.04.006. eCollection 2021 Sep. PMID: 34401614; PMCID: PMC8358283.
Copy Download .nbib Format: NLM
Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report.

Surgical case reports

Kayahara M, Onishi I, Makita N, Kano S, Munemoto M, Yagi Y, Minami M, Orita N, Komura T, Kurose N.
PMID: 33847839
Surg Case Rep. 2021 Apr 13;7(1):90. doi: 10.1186/s40792-021-01172-0.

BACKGROUND: Pancreatic acinar cell carcinoma (PACC) is a rare exocrine malignant tumor. Its widespread intraductal extension into the main pancreatic duct (MPD) is also rare.CASE PRESENTATION: We report the case of a 71-year-old man with PACC with MPD extension....

Cite
Kayahara M, Onishi I, Makita N, et al. Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report. Surg Case Rep. 2021;7(1):90doi: 10.1186/s40792-021-01172-0.
Kayahara, M., Onishi, I., Makita, N., Kano, S., Munemoto, M., Yagi, Y., Minami, M., Orita, N., Komura, T., & Kurose, N. (2021). Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report. Surgical case reports, 7(1), 90. https://doi.org/10.1186/s40792-021-01172-0
Kayahara, Masato, et al. "Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report." Surgical case reports vol. 7,1 (2021): 90. doi: https://doi.org/10.1186/s40792-021-01172-0
Kayahara M, Onishi I, Makita N, Kano S, Munemoto M, Yagi Y, Minami M, Orita N, Komura T, Kurose N. Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report. Surg Case Rep. 2021 Apr 13;7(1):90. doi: 10.1186/s40792-021-01172-0. PMID: 33847839; PMCID: PMC8044282.
Copy Download .nbib Format: NLM
MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.

Oral oncology

Noji R, Kano Y, Hirai H, Onishi I, Nishii N, Yoshimura R, Miyake S, Ikeda S, Harada H.
PMID: 34896892
Oral Oncol. 2021 Dec 09;124:105666. doi: 10.1016/j.oraloncology.2021.105666. Epub 2021 Dec 09.

Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC) have a poor prognosis. Recently, the use of immune checkpoint inhibitors (ICIs) for drug treatment has been expanding . However, the response rate to...

Cite
Noji R, Kano Y, Hirai H, et al. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral Oncol. 2021;124:105666doi: 10.1016/j.oraloncology.2021.105666.
Noji, R., Kano, Y., Hirai, H., Onishi, I., Nishii, N., Yoshimura, R., Miyake, S., Ikeda, S., & Harada, H. (2021). MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral oncology, 124105666. https://doi.org/10.1016/j.oraloncology.2021.105666
Noji, Rika, et al. "MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma." Oral oncology vol. 124 (2021): 105666. doi: https://doi.org/10.1016/j.oraloncology.2021.105666
Noji R, Kano Y, Hirai H, Onishi I, Nishii N, Yoshimura R, Miyake S, Ikeda S, Harada H. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral Oncol. 2021 Dec 09;124:105666. doi: 10.1016/j.oraloncology.2021.105666. Epub 2021 Dec 09. PMID: 34896892.
Copy Download .nbib Format: NLM
Showing 1705 to 1708 of 1708 entries